SHERIDAN, WYOMING - March 31, 2026 - Climate resilience planning is moving into 2026 healthcare procurement, regulatory, and supply-chain decisions as the European Commission develops an Integrated Climate Resilience Framework that could shape how medical technology manufacturers invest, document compliance, and maintain uninterrupted access to devices and diagnostics. In February 2026, MedTech Europe responded to the Commission's public consultation and argued for a holistic healthcare system response built on smart investments, better coordination, consistent policy frameworks, and improved collaboration across healthcare actors.
Framework direction
The Commission is preparing the new European integrated framework for climate resilience for adoption in Q4 2026. The consultation sits against the European Climate Risk Assessment, which identified 36 key climate risks in Europe that interact to create system-wide challenges. The source ties those risks not only to environmental exposure but also to pressure on supply chains, pricing, economic and financial stability, fiscal sustainability, and public health if climate change and other risk factors are not properly addressed.
MedTech Europe's position is that the framework should enable climate resilience and risk management through collaboration and partnerships across the healthcare system. Its submission links resilience to financial sustainability and continued access to care, making climate policy relevant not only to environmental targets but also to service continuity for providers and patients. The group also calls for global carbon pricing, more renewable energy, and greater energy efficiency, while arguing that synergies between the Green and Digital agendas can improve overall healthcare system efficiency.
Regulatory alignment and supply continuity
A central industry concern is how climate legislation will interact with the medical technology sector's existing regulatory structure. MedTech Europe says future legislation should remain consistent with the sector-specific requirements already set by Regulation (EU) 2017/745 on Medical Devices and Regulation (EU) 2017/746 on In-Vitro Diagnostic Medical Devices. That position frames climate resilience not as a stand-alone environmental file, but as a policy layer that must work alongside already stringent device and IVD compliance obligations.
The association also presses for legislation that improves the sustainability performance of medical technologies from a life-cycle perspective and for realistic transition pathways that give manufacturers and their manufacturing supply chains sufficient time to adapt. The operational issue is continuity: patients and practitioners are expected to rely on uninterrupted access to medical technologies during any transition. MedTech Europe further argues for truly harmonised rules that reinforce the European internal market, describing that market as a catalyst for both environmental protection and a competitive EU medical technology industry.
Business impact
Procurement leads and supply chain officers in hospitals and healthcare systems face a 2026 planning shift because climate resilience is increasingly tied to product availability, supplier readiness, and long-term cost stability. They should expect vendor selection and sourcing discussions to move beyond unit price toward evidence of transition planning, manufacturing resilience, and the supplier's ability to maintain access during regulatory and energy-related changes. For EU-facing suppliers, alignment with the internal market and consistency with MDR and IVDR requirements will matter in tender qualification and risk review.
Regulatory affairs teams and operations directors at medical technology manufacturers will need to map how future climate resilience measures could intersect with existing EU device and IVD obligations, particularly where life-cycle sustainability expectations, energy efficiency measures, and carbon-related policies affect production and distribution. Budget owners and technology roadmap teams should also treat the Green and Digital agendas as linked rather than separate workstreams, because the source explicitly positions those synergies as a route to system efficiency. In practice, 2026 decisions are likely to center on compliance sequencing, manufacturing transition timing, and investments that protect both sustainability performance and uninterrupted care delivery across the European Union.